J Korean Orthop Assoc.  1996 Apr;31(2):247-254. 10.4055/jkoa.1996.31.2.247.

Effect of Dehydroepiandrosterone on the Osteoporosis Induced by Oophorectomy in the Rat

• Suk SI
• Seong SC
• Lee CK
• Lee MC
• Chung SS
• Park SC
• Song KY

• KMID: 2423601
• DOI: http://doi.org/10.4055/jkoa.1996.31.2.247

Abstract

Dehydroepiandrosterone(DHEA) was administered to rats to investigate the efficacy of DHEA in prevention of the process of osteoporosis induced by oophorectomy. Female Sprague-Dawley rats, aged five months, were divided into three groups; Group 1(40 rats), sham operation as control; group 2(40 rats), bilateral oophorectomy; and group 3(20 rats), intraperitoneal injection of 10mg of DHEA every other day from 4 weeks after bilateral oophorectomy. In group 1 and 2, five rats of each group were sacrificed weekly until the 8th week. In group 3, five rats were killed weekly from 1 week to 4 weeks after DHEA administration. Trabecular bone area(TBA) of proximal metaphysic of left tibia was obtained by quantitative image analysis system. In group 1, TBA was not changed with time after sham operation, In group 2, TBA decreased progressively through eight weeks after oophorectomy. In group 3, TBA's were higher than those of group 2, but they were still lower than those of group 1. These data suggested that DHEA, administered to rats from 4 weeks to 8 weeks after bilateral oophorectomy, may partially recover the osteoporosis or delay the progression of the osteoporotic change until 8 weeks after the oophorectomy.

Keyword

Oophorectomy; Osteoporosis; Dehydroepiandrosterone; Rat

MeSH Terms

Animals
Dehydroepiandrosterone*
Female
Humans
Injections, Intraperitoneal
Metaphysics
Osteoporosis*
Ovariectomy*
Rats*
Rats, Sprague-Dawley
Tibia
Dehydroepiandrosterone

Figure

• 

  Fig. 1 Method of the measurement of the trabecular bone area of proximal tibia. At metaphysis of the tibia, rectangular shape of bone was selected, whose reference area was 0.196304 × 107 µm2 and breadth was approximately 2/3 of that of epiphyseal plate. Area of each trabecular bone was automatically calculated and aver aged with computer system. The total trabecular bone area of each sample was calculated by average area of each trabecular bone and number of trabecula in the rectangle.

• 

  Fig. 2A-H Histological changes of the proximal tibia before and after oophorectomy. (Hemato-xylin-Eosin Staining, x 40 except(A) (A) 1 week after sham operation(x 20). Trabecular pattern of the osteoid is condense and well preserved in both the epiphysis and metaphysis (B) 1 week after oophorectomy. Trabecular margin become coarse, but the dense trabecular architecture is still preserved. (C) 5 weeks after oophorectomy. Trabecular bones are reduced in size and number. (D) 5 weeks after oophorectomy and 1 week after administration of DHEA. Trabecular bones are slightly larger and more abundant comparing to those of 5 weeks after oophorectomy(C). (E) 6 weeks after oophorectomy. Trabecular portion is reduced and the cellular and vacuolar portion of marrow become more predominat. (F) 6 weeks after oophorectomy and 2 weeks after administration of DHEA. Trabeculae are more abundant comparing to those of 6 weeks after oophorectomy(E). (G) 8 weeks after oophorectomy. Severe reduction in the size and the number of the trabeculae is observed. (H) 8 weeks after oophorectomy and 4 weeks after administration of DHEA. Abundant trabeculae are visible, but still less abundant than those seen in the sham operation group(A).

• 

  Fig. 3 Weekly measurement of trabecular bone area(TBA) of proximal tibiae of each group. In group 1, the TBA was not changed with time after sham operation. After oophorectomy in group 2, the TBA decreased progres sively. In group 3, TBA’s were higher than those of group 2. but still lower than those seen in group 1.1

Reference

1. Arnaud CD. An Integrated View of the Role of the Endocrine System in the Genesis of the Osteoporosis Associated with Aging. Osteoporosis International. 1993; 3(suppl.1):37–39,.

2. Daynes RA, Araneo BA, Ershler WB, Maloney C, Li GZ, Ryu SY. Altered Regulation of IL-6 Production with Normal Aging. Possible Linkage to the Age-Associated Decline in Dehydroepiandrosterone and its Sulfated Derivative. Journal of Immunology. 1993; 150(12):5219–5230.

3. Durbridge TC, Morris HA, Parson AM, Parkinson IH, Moore RJ, Porter S, Need AG, Nordin BEC, Vernon-Roberts B. Progressive Cancellous Bone Loss in Rats after Adrenaectomy and Oophorec-tomy. Calcified Tissue International. 1990; 47:383–387.

4. Eriksen ER, Colvard PS, Berg NJ, Graham ML, Mann KG, Speltberg TC, Riggs BL. Evidence of Estrogen Receptor in Normal Human Osteoblast-Like Cell. Science. 1981; 241:84–86.

5. Ershler WB, Sun WH, Binkley N, Volk MJ, Gravenstein S, Kamoske G, Klopp RG, Roecker EB, Daynes RA, Welndruch R. Interleukin-6 and Aging. Blood Levels and Mononuclear Cell Production Increase with Advancing Age and In Vitro Production Is Modifiable by Dietary Restriction. Lymphokine and Cytokine Research. 1993; 12({4)):225–23Q.

6. Girasole G, Jilka RL, Passeri G, Boswell S, Boder G, Willams DC, Manolagas SC. 17β-Estradiol Inhibits Interleukin-6 Production by Bone Marrow-derived Stromal Cells and Osteoblasts in Vitro. Journal of Clinical Investigation. 1992; 89:883–891.

7. Grkan L, Ekel A, Gautvik KM, Langeland N, Ronningen H, Solheim LF. Bone changes after Castration in Rats. A Model for Osteoporosis. Acta Orthopedica Scandinavia,. 1986; 57:67–70.

8. Jayo MJ, Weaver DS, Adams MR, Rankin SE. Effects on Bone of Surgical Menopause and Estrogen Therapy with or without Progesteron Replacement in Cynomolgus Monkeys. Am J Obstet Gynecol. 1990; 193:614–618.

9. Jilka RL, Hangoc G, Girasole G, Passeri G, Willams PCA, brains JS, Boyce B, Broxmeyer H, Manolagas SC. Increased Osteoclast Development after Estrogen Loss. Mediation by Interleukin-6. Science. 1992; 257:88–91.

10. Kalu DN, Liu CC, Hardin RR, Mollis BW. The Aged Rat Model of Ovarian Hormone Deficiency Bone Loss. Endocrinology. 1989; 124:7–16.

11. Lindgren U, DeLuca HF. Role of Parathyroid Hormone and 1,25-Dihydroxyvitamin D3 in the Development of Osteopenia in Oophoreetomized Rats. Calcified Tissue International. 1982; 34:510–514.

12. Lindsay R. Estrogen Therapy in the Prevention and Management of Osteoporosis. Am J Obstet Gynecol. 1987; 156:1347–1351.

13. Malluehe HH, Sherman D, Meyer W, Massry SG. A New Semiautomatic Method for Quantitative Static and Dynamic Bone Histology. Calcified Tissue International. 1982; 34:439–448.

14. Onto H, Masuzawa T, Ikeda T, Suda Y, Makita K, Nozawa S. Which is More Osteoporosis-inducing Menopause or Oophorectomy? Bone and Mineral. 1992; 19((3)):273–285.

15. Orimo H, Fujita T, Yoshikawa M. Increased Sensitivity of Bone to Parathyroid Hormone in Ovariectomized Rats. Endocrinology. 1972; 90:760–763.

16. Recker RR, Saville PD, Heaney RP. Effect of Estrogen and Calcium Carbonate on Bone Loss in Postmenopausal Women. Annals of Internal Medicine. 1977; 87:649–655.

17. Schlaghccke R, Kley HK, Juli E. Age-related Changes in 11β-hydroxyandrostenedione Concentration in Normal and Osteoporotic Women. Journal of Steroid Biochemistry and Molecular Biology. 40:1991; ((4-6)):731–733.

18. Weksler ME. Immune Senescence and Adrenal Steroids. Immune dysregulation and the Action of Dehydroepinadrosterone(DHEA) in Old Animals. European Journal of Clinical Pharmacology,. 1993; 45(Suppl 1):S21–23. Discussion S43-44.

19. Wild RA, Buchanan JR, Myers C, Demers LM. Declining Adrenal Androgen. an Association with Bone Loss in Aging Women. Proceedings of the Society for Experimental Biology and Medicine,. 1987; 186((3)):355–360.